Loading...
AMBICA INTERNATIONAL CORPORATION — Pioglitazone Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #13 buyer for Pioglitazone · $601.5K import value · 59 shipments · PHILIPPINES · DGFT Verified
AMBICA INTERNATIONAL CORPORATION is the #13 importer of Pioglitazone from India with $601.5K in import value and 59 verified shipments. AMBICA INTERNATIONAL CORPORATION holds a 1.6% market share in Pioglitazone imports based in PHILIPPINES. The company sources from 2 verified suppliers across 32 formulations shipped to 1 country. Overall, AMBICA INTERNATIONAL CORPORATION imports 9 pharmaceutical products worth $5.6M across 7 therapeutic categories.
Verified from 59 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MEDLEY PHARMACEUTICALS LIMITED | $597.2K | 58 | 99.3% |
| UNOSOURCE PHARMA LIMITED | $4.3K | 1 | 0.7% |
AMBICA INTERNATIONAL CORPORATION sources Pioglitazone from 2 verified Indian suppliers based on 59 customs records. The primary supplier is MEDLEY PHARMACEUTICALS LIMITED accounting for 99.3% of imports.
Buyers ranked immediately above and below #13 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | AJANTA PHARMA PHILIPPINES INC | PHILIPPINES | $800.0K | 16 | $50.0K |
| 12 | RISING PHARMA HOLDINGS, INC. , | UNITED STATES | $657.5K | 32 | $20.5K |
| 13 | AMBICA INTERNATIONAL CORPORATION ★ | PHILIPPINES | $601.5K | 59 | $10.2K |
| 14 | MACLEODS PHARMA USA ,INC | UNITED STATES | $531.9K | 57 | $9.3K |
| 15 |
AMBICA INTERNATIONAL CORPORATION ranks #13 among 293 Pioglitazone importers from India. Average shipment value of $10.2K compared to the market average of $71.8K. The closest competitors by value are AJANTA PHARMA PHILIPPINES INC and RISING PHARMA HOLDINGS, INC. ,.
Destination countries from 59 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $601.5K | 59 | 100.0% |
AMBICA INTERNATIONAL CORPORATION imports Pioglitazone to 1 country. The primary destination is PHILIPPINES receiving 100.0% of shipments worth $601.5K.
| Formulation | Value | Shipments |
|---|---|---|
| MEDICAMENTS - PIOGLITAZONE (AS HYDROCHLO | $120.3K | 7 |
| MEDICAMENTS - PIOGLITAZONE AS HYDROCHLO | $59.2K | 4 |
| PIOGLITAZONE (as Hydrochloride) 30mg Tab | $58.3K | 2 |
| PIOGLITAZONE (as Hydrochloride) 30mg Tablet PPAR (PACK OF 3 X 10T) | $37.4K | 3 |
| MEDICAMENTS- PIOGLITAZONE AS HYDROCHLOR | $37.0K | 2 |
| MEDICAMENTS:PIOGLITAZONE AS HYDROCHLORIDE 30MG TABLET PPAR5300 PACK FOC 52500 PACKX3X10=1575000 TABS | $33.0K | 1 |
| MEDICAMENTS PIOGLITAZONE (AS HYDROCHLORIDE) 30MG TABLET PPAR (PACK OF 3 X 10T)NOS | $23.6K | 3 |
| MEDICAMENTS PIOGLITAZONE AS HYDROCHLORIDE 30MG TABLET PPAR PACK OF 3 X 10T | $23.0K | 1 |
India exported $21.0M worth of Pioglitazone through 2,674 shipments from 115 suppliers to 70 countries, serving 293 buyers globally. AMBICA INTERNATIONAL CORPORATION imports $601.5K of this total, accounting for 1.6% of India's Pioglitazone exports with 59 shipments from PHILIPPINES. This is verified from 59 customs shipment records covering 32 distinct formulations.
AMBICA INTERNATIONAL CORPORATION's average Pioglitazone order value is $10.2K per consignment, based on 59 shipments totaling $601.5K. AMBICA INTERNATIONAL CORPORATION is based in PHILIPPINES and ranks #13 among all Pioglitazone importers from India by value. The company sources from 2 verified suppliers in India.
AMBICA INTERNATIONAL CORPORATION sources Pioglitazone from 2 verified Indian suppliers: MEDLEY PHARMACEUTICALS LIMITED ($597.2K, 99.3%), UNOSOURCE PHARMA LIMITED ($4.3K, 0.7%). This is based on 59 customs records.
AMBICA INTERNATIONAL CORPORATION ranks #13 among 293 Pioglitazone importers from India with a 1.6% market share. The top 3 importers are RISING PHARMA HOLDINGS, INC. ,. ($2.8M), RISING PHARMA HOLDINGS, INC. ($2.6M), AUROLOGISTICS LLC (AUROBINDO PHARMA ($2.4M). AMBICA INTERNATIONAL CORPORATION processed 59 shipments from PHILIPPINES.
AMBICA INTERNATIONAL CORPORATION also imports these diabetes & endocrine products. Each links to the detailed product page.
AMBICA INTERNATIONAL CORPORATION imports 9 products worth $5.6M. Beyond Pioglitazone, top products include Immunoglobulin, Natural, Colchicine, Folic, Glimepiride. View the complete AMBICA INTERNATIONAL CORPORATION profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Pioglitazone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for AMBICA INTERNATIONAL CORPORATION's Pioglitazone imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AMBICA INTERNATIONAL CORPORATION
Full Company Profile →
9 products · $5.6M total trade · 7 categories
| UNITED STATES |
| $505.2K |
| 27 |
| $18.7K |
| MEDICAMENTS:PIOGLITAZONE (AS HYDROCHLORID) 30MG TABLET PPAR (PACK OF 3 X 10T) (37000 PACKX3X10=1110000 TABS) | $22.2K | 3 |
| MEDICAMENTS - (PIOGLITAZONE (AS HYDROCHL | $19.9K | 6 |
AMBICA INTERNATIONAL CORPORATION imports 32 distinct Pioglitazone formulations from India. The top formulation is MEDICAMENTS - PIOGLITAZONE (AS HYDROCHLO with 7 shipments worth $120.3K.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 70+ countries, 293+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for AMBICA INTERNATIONAL CORPORATION.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pioglitazone. For current order-level data, contact TransData Nexus.